Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about ARID1A: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet. View on Wiki →
| Gene Symbol | ARID1A |
| Chromosome | 1p36.11 |
| Function | BAF chromatin remodeling complex subunit |
| Exons | 20 |
| Gene Type | Protein-coding |
| Pathways | Apoptosis, Dna Repair, Epigenetic, Immunotherapy, Mtor |
| NCBI Gene ID | 8289 |
| Ensembl ID | ENSG00000117713 |
| GeneCards | ARID1A |
| Human Protein Atlas | ARID1A |
| HGNC ID | 11110 |
| Protein | ARID1A protein |
| Key Domains | ARID, DUF3518, nuclear localization signal |
| Disease Associations | Alzheimer's disease, Coffin-Siris syndrome, intellectual disability |
| Numerous LoF variants | Truncating |
| Associated Diseases | Als, BREAST CANCER, CANCER, Carcinoma |
| Interactions | ATR, RNASEH2B, TREX1, CD8, STING, SMARCA4 |
| KG Connections | 195 knowledge graph edges |
| Databases | GeneCardsUniProtHPASTRING |
Knowledge base pages for this entity
graph TD
ARID1A["ARID1A"] -->|"associated"| Tumor["Tumor"]
style Tumor fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#fff
ARID1A["ARID1A"] -->|"associated"| Cancer["Cancer"]
style Cancer fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#fff
ARID1A["ARID1A"] -->|"upstream of"| cytosolic_ssDNA["cytosolic ssDNA"]
style cytosolic_ssDNA fill:#1a2a3a,stroke:#ffd54f,stroke-width:1px,color:#fff
ARID1A["ARID1A"] -->|"associated"| KRAS["KRAS"]
style KRAS fill:#1a2a3a,stroke:#ce93d8,stroke-width:1px,color:#fff
ARID1A["ARID1A"] -->|"associated"| GENES["GENES"]
style GENES fill:#1a2a3a,stroke:#ce93d8,stroke-width:1px,color:#fff
ARID1A["ARID1A"] -->|"associated"| Ovarian_Cancer["Ovarian Cancer"]
style Ovarian_Cancer fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#fff
ARID1A["ARID1A"] -->|"associated"| Als["Als"]
style Als fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#fff
PTEN["PTEN"] -->|"associated"| ARID1A["ARID1A"]
style PTEN fill:#1a2a3a,stroke:#ce93d8,stroke-width:1px,color:#fff
PIK3CA["PIK3CA"] -->|"associated"| ARID1A["ARID1A"]
style PIK3CA fill:#1a2a3a,stroke:#ce93d8,stroke-width:1px,color:#fff
TP53["TP53"] -->|"associated"| ARID1A["ARID1A"]
style TP53 fill:#1a2a3a,stroke:#ce93d8,stroke-width:1px,color:#fff
FBXW7["FBXW7"] -->|"associated"| ARID1A["ARID1A"]
style FBXW7 fill:#1a2a3a,stroke:#ce93d8,stroke-width:1px,color:#fff
CANCER["CANCER"] -->|"therapeutic target"| ARID1A["ARID1A"]
style CANCER fill:#1a2a3a,stroke:#ce93d8,stroke-width:1px,color:#fff
style ARID1A fill:#4a1a6b,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0,font-weight:bold| Target | Relation | Type | Str |
|---|---|---|---|
| Tumor | associated_with | disease | 1.00 |
| cytosolic ssDNA | upstream_of | phenotype | 0.95 |
| Cancer | associated_with | disease | 0.95 |
| CANCER | associated_with | gene | 0.90 |
| Cancer | activates | disease | 0.85 |
| Tumor | activates | disease | 0.85 |
| KRAS | associated_with | gene | 0.80 |
| GENES | associated_with | gene | 0.80 |
| Cancer | expressed_in | disease | 0.75 |
| Tumor | expressed_in | disease | 0.75 |
| Cancer | regulates | disease | 0.75 |
| Ovarian Cancer | associated_with | disease | 0.75 |
| Als | associated_with | disease | 0.75 |
| PIK3CA | associated_with | gene | 0.70 |
| TP53 | associated_with | gene | 0.70 |
| PI3K | expressed_in | gene | 0.70 |
| CTNNB1 | associated_with | gene | 0.70 |
| GENES | contributes_to | gene | 0.70 |
| DNA | regulates | gene | 0.70 |
| Immune Checkpoint | inhibits | pathway | 0.70 |
| DNA | associated_with | gene | 0.70 |
| Epigenetic | regulates | pathway | 0.70 |
| CANCER | causes | disease | 0.70 |
| Hepatocellular Carcinoma | risk_factor_for | disease | 0.68 |
| Carcinoma | therapeutic_target | disease | 0.65 |
| Cancer | therapeutic_target | disease | 0.65 |
| Als | therapeutic_target | disease | 0.65 |
| Carcinoma | activates | disease | 0.65 |
| Ms | activates | disease | 0.65 |
| Colorectal Cancer | expressed_in | disease | 0.65 |
| Cancer | treats | disease | 0.65 |
| Als | treats | disease | 0.65 |
| Tumor | inhibits | disease | 0.65 |
| Als | regulates | disease | 0.65 |
| Gastric Cancer | inhibits | disease | 0.65 |
| Carcinoma | associated_with | disease | 0.65 |
| Breast Cancer | associated_with | disease | 0.65 |
| Inflammation | associated_with | disease | 0.65 |
| Pancreatic Cancer | associated_with | disease | 0.65 |
| Prostate Cancer | activates | disease | 0.65 |
| Inflammation | activates | disease | 0.65 |
| Cancer | contributes_to | disease | 0.65 |
| Renal Cell Carcinoma | contributes_to | disease | 0.65 |
| Carcinoma | contributes_to | disease | 0.65 |
| Als | contributes_to | disease | 0.65 |
| Colorectal Cancer | associated_with | disease | 0.65 |
| Gastric Cancer | associated_with | disease | 0.65 |
| Als | inhibits | disease | 0.65 |
| Aging | activates | disease | 0.65 |
| Aging | encodes | disease | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| PTEN | associated_with | gene | 0.90 |
| PIK3CA | associated_with | gene | 0.60 |
| TP53 | associated_with | gene | 0.60 |
| SMARCA4 | interacts_with | gene | 0.60 |
| ASH1L | contributes_to | gene | 0.60 |
| FGFR3 | associated_with | gene | 0.60 |
| PTEN | contributes_to | gene | 0.60 |
| BAX | regulates | gene | 0.60 |
| BRAF | associated_with | gene | 0.60 |
| TGFBR2 | regulates | gene | 0.60 |
| CD8 | activates | gene | 0.60 |
| CDKN2A | activates | gene | 0.60 |
| APC | associated_with | gene | 0.60 |
| PMS2 | activates | gene | 0.60 |
| CACNA1G | activates | gene | 0.60 |
| CDKN2A | encodes | gene | 0.60 |
| MLH1 | activates | gene | 0.60 |
| NEUROG1 | activates | gene | 0.60 |
| FBXW7 | associated_with | gene | 0.60 |
| CANCER | therapeutic_target | gene | 0.60 |
| KRAS | activates | gene | 0.60 |
| P53 | activates | gene | 0.60 |
| CANCER | activates | gene | 0.60 |
| APOPTOSIS | inhibits | gene | 0.60 |
| CANCER | expressed_in | gene | 0.60 |
| APOPTOSIS | regulates | gene | 0.60 |
| CANCER | regulates | gene | 0.60 |
| GENES | interacts_with | gene | 0.60 |
| DNA | associated_with | gene | 0.60 |
| ALK | associated_with | gene | 0.60 |
| ATEZOLIZUMAB | associated_with | drug | 0.50 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||